August 26, 2016
Enrollment of the first subjects in the pharmacokinetics study on Sarcopenia. Read the Press Release
July 29, 2016
BIOPHYTIS receives approval of bpifrance for an innovation loan of €1.1M to finance the SARA-PK trial. Read the press release
July 25, 2016
BIOPHYTIS receives Belgian regulatory authorization to start Sarconeos pharmacokinetics study in elderly healthy volunteers (SARA-PK). Read the Press Release
June 10, 2016
Results of the Combined General Shareholders’ Meeting held on June 10, 2016. Read the Press Release
May 04, 2016
In french: Assemblée Générale convoquée le 10 juin 2016. Téléchargez le communiqué de presse
April 29, 2016
BIOPHYTIS unveils its clinical development strategy in the United States, as it communicates its 2015 Document de Référence. Download the Press Release
April 12, 2016
BIOPHYTIS to Present Key Research Findings on Company’s Two Lead Compounds at Upcoming Scientific Conferences. Read the Press Release
March 17, 2016
BIOPHYTIS: 2015 Annual Results. Read the Press Release
March 11, 2016
BIOPHYTIS receives positive scientific advice on SARCOB BIO101 clinical development plan from Belgian regulatory authority. Download the Press Release
January 20, 2016
American LifeSci Capital initiates coverage of Biophytis stock. Téléchargez le communiqué de presse. Téléchargez le communiqué de presse